Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immune Persistence of Twinrix in Healthy Children
NCT00289744Phase 3Completed
- Sponsor
- GSK
- Start
- Feb 2004
- Primary completion
- Apr 2009
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, open-label trial of hepatitis b vaccine recombinant in hepatitis A (HAV) and hepatitis B (HBV) (3 arms), sponsored by GSK. Primary endpoints: Anti-hepatitis A Virus (Anti-HAV) Antibody Concentration at Year 10, Anti-hepatitis B Surface Antigen (Anti-HBs) Antibody Concentration at Year 10 and 5 more. Started Feb 2004; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis A (HAV)hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00289744.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289744.